A safety and efficacy study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia.
Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A multinational, multicenter, open-label, rater-blinded Phase II study. Effects of N-Acetyl-L-Leucineon Ataxia-Telangiectasia (A-T): A multinational, multicenter, open-labe ...
Ataxia-Telangiectasia (A-T) MedDRA version: 20.0;Level: SOC;Classification code 10010331;Term: Congenital, familial and genetic disorders;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] Ataxia-Telangiectasia (A-T) MedDRA version: 20.0;Level: SOC;Classification code 10010331;Term: Conge ...
N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)
Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study Effects of N-Acetyl-L-Leucineon Ataxia-Telangiectasia (A-T): A Multinational, Multicenter, Open-labe ...
A safety and efficacy study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia
Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A multinational, multicenter, open-label, rater-blinded Phase II study. - IB1001-203 Effects of N-Acetyl-L-Leucineon Ataxia-Telangiectasia (A-T): A multinational, multicenter, open-labe ...
To demonstrate that N-Acetyl-L-Leucine is effective in improving symptoms, functioning, and quality of life in patients with Ataxia-Telangiectasia (A-T);Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] To demonstrate that N-Acetyl-L-Leucineis effective in improving symptoms, functioning, and quality o ...